Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Sort by: Date|Relevance

Biopharma's Phase 3 Trial Results in Migraine 'Robust,' 'Impressive'

These topline data and next steps for the therapeutic are reviewed in a Ladenburg Thalmann report. In a Dec. 30 research note, analyst Matthew Kaplan reported that Ladenburg Thalmann increased its price target on Buy-rated Axsome Therapeutics Inc. (AXSM:NASDAQ) to $...

Should We Rethink Nuclear Power?

While it seems to fly in the face of everything we believe and have been taught about nuclear power, it may actually be the safest form of power production that we have. Ironically, the immense potency of the power of splitting an atom is simultaneously what makes nuclear weap...

Alder BioPharmaceuticals Shares Surge 80% on Acquisition News

Shares of migraine treatment research firm Alder BioPharmaceuticals opened 84% higher today after the company announced that it has agreed to be acquired by H. Lundbeck for $1.95 billion. Early this morning, clinical-stage biopharmaceutical company Alder BioPharmaceu...

Target Raised on Explorer; Val d'Or Project Is 'Gift That Keeps on Giving

The latest drill results are delivered and interpreted in an iA Securities report. In an Aug. 1 research note, analyst George Topping reported that iA Securities raised its target price on Wesdome Gold Mines Ltd. (WDO:TSX) to CA$7.50 per share from CA$7 bec...

Buzz on the Bullboards: What Goes Up…

The markets might be up in the new year so far, but the sentiment has been far from universal. 2020 has been a great year for some and a terrible start for others. If a stock that goes up must come down, will the reverse end up being true as well? That’s wh...

Tired of Big Box Cannabis? Investors Should Consider the Craft Sector

The craft cannabis industry evolved in 2021 to become a major disruptor to big-box cannabis. Yet, micro-cultivators still face hurdles to get their product to market as demand from younger consumers increases. Solutions are needed. One company at the forefront of this chang...

Buzz on the Bullboards: The Top Last-Minute Movers of 2021

Expecting the markets to be relaxed heading into the holidays? Hardly. Many investors and brokers know that this is the time to shine. With every twist and turn the global economy has been throwing our way, the right move is staying active. This past week, it seems ma...

The Great Dichotomy

One of the advantages of being a sexagenarian is that after forty years investing in stocks, bonds, commodities, and currencies you have a pretty good idea when something is not exactly "right." If you have lived a good, normal life and you still have decent control of ov...

The Vertically-Integrated Cannabis Co. that You Need to Know About

(Click image to play video) Few companies in the North American cannabis space can boast the sheer bounty of product offerings, blue-chip management experience, and extraordinary shareholder value that this established Medford Oregon-based Company can. Halo Ca...